Navigation Links
U.S. Stem Cell Research Seems to Focus on Two Lines
Date:8/7/2009

Experts urge federal government to preserve study options

FRIDAY, Aug. 7 (HealthDay News) -- Only two of 21 approved human embryonic stem cell lines are routinely used by researchers in the United States, says a new study.

The study found that two cell lines, known as H1 and H9, accounted for 941 of 1,217 requests, or 77 percent, placed by scientists since 1999 for human embryonic stem cell lines housed at the two largest stem cell banks in the country.

Another line, H7, was requested 111 times, and 13 other lines were requested fewer than 10 times.

The study's authors also found that H9 was discussed in 83 percent of 534 published studies from 1999 to 2008, H1 was discussed in 61 percent and H7 in 24 percent. The total is more than 100 percent because many studies used more than one cell line.

"I was surprised by the results," Christopher Scott, director of Stanford University's Program on Stem Cells in Society, said in a news release. "I never imagined that we would find that three-fourths of the requests would be for the same two cell lines."

The study appears in the Aug. 7 issue of Nature Biotechnology.

Scott and his fellow researchers said the findings raise concerns about the reauthorization process of stem cell lines under way at the U.S. National Institutes of Health. If the lines that have been in use are excluded from federal funding because of ethical considerations, they said, scientists might abandon research on them in favor of other cell lines.

However, they added, the two most-used lines might have abnormalities or other characteristics that would make them less useful than newer lines.

Future NIH policies should preserve scientists' ability to continue work on the well-studied lines while also encouraging the study of new lines expected to become eligible for federal funding, Scott said.

More information

The U.S. National Institutes of Health has more about stem cells.



-- Robert Preidt



SOURCE: Stanford University, news release, Aug. 7, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Yerkes researchers propose ambitious new strategies for AIDS vaccine research
2. LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense
3. Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts
4. UC design research points the way so you wont get lost at the hospital
5. Sperm Cell Insights May Aid Stem Cell Research
6. New Research Suggests Most Are Willing to Make Tradeoffs and Would Embrace Comprehensive Health Care Reform
7. EHE International Supports The Michael J. Fox Foundation for Parkinsons Research
8. Cryo-Cell to Present Novel Adult Stem Cell Research During 2009 China Medical Biotech Forum
9. Dartmouth gets $3 million from the National Science Foundation for IT research in health care
10. The Scleroderma Foundation Applauds Introduction of First Bill in the Senate Promoting Research and Awareness of Scleroderma
11. Researchers Identify New Method to Selectively Kill Metastatic Melanoma Cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.S. Stem Cell Research Seems to Focus on Two Lines
(Date:4/25/2017)... , ... April 25, 2017 , ... Back Pain ... and back pain with a reputable physician in their area, announces the launch of ... patient information for patients who are looking for reputable physicians to help them with ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality ... problems, I focus on preventative care with all my patients to alleviate possible future issues. ... feel free to contact my office and my trained staff will assist you in any ...
(Date:4/25/2017)... ... ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will be featured ... publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is an Emergency ... He also serves as Medical Director for the Bureau of Emergency Medical Services and ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
(Date:4/24/2017)... Massachusetts (PRWEB) , ... April 24, 2017 , ... ... will help busy nursing professionals advance their careers. Beginning in the fall of 2017, ... Nursing (BSN) degree in as few as 16 months and for as little as ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 ... stimulate an immune response in pets such as ... products are of various types such as Attenuated ... Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated ... as virus or bacteria, which have been weakend ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and ... This is in conjunction with this morning,s announcement of ... Thrombosis and Nutritional Insufficiency businesses. Cardinal Health ... operations will be at the bottom of its previous ...
Breaking Medicine Technology: